KMV002
/ Chimigen Biomedical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 09, 2026
A Study of KMV002 in Patients With mAPMR Prostate Cancer
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Chimivac INC
First-in-human • New P1 trial • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1